RxDoctor Payments Data

Betty Pelletier

Adult Health · Chapin, SCNPI 1548392442

Payments from drug & device makers

$743in general payments, 2019–2025

Across 40 payments — averaging $18.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$170
  • AstraZeneca$91
  • Inari Medical, Inc.$91
  • Novo Nordisk$69
  • Lilly USA, LLC$65
  • GSK$50
  • plus $206 from 10 others

What the payments were for

  • Food & beverage$743100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$743 in reported general payments places this provider in the 45th percentile of 292 adult health providers in South Carolina.

See all adult health providers in South Carolina

Medicare billing

Part B allowed, 2024
$170,201
Medicare patients
316
Services billed
5,040

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban65$71,319
OzempicSemaglutide47$58,641
MounjaroTirzepatide41$47,506
XifaxanRifaximin12$36,966
TrulicityDulaglutide35$32,301
RybelsusSemaglutide19$24,961
FarxigaDapagliflozin Propanediol19$12,312
LinzessLinaclotide12$10,185
XareltoRivaroxaban16$8,245
JanuviaSitagliptin Phosphate11$6,069
Lantus SolostarInsulin Glargine,hum.Rec.Anlog32$5,035
Levothyroxine Sodium424$4,772
Duloxetine Hcl140$4,440
SymbicortBudesonide/Formoterol Fumarate11$4,385
Metoprolol Succinate247$3,982

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$69$83,60266 claims
Lilly USA, LLCMounjaro, Trulicity$65$79,80876 claims
PfizerEliquis$49$71,31965 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan$16$36,96612 claims
AstraZenecaFarxiga, Symbicort$91$16,69730 claims
AbbVieLinzess, Synthroid$14$12,89566 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 292 adult health providers in South Carolina.

Other adult health in Chapin

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →